Reply to thread

Message: <blockquote data-quote="Nelson Vergel" data-source="post: 152171" data-attributes="member: 3">The price of the new esketamine (Brand name: Spravato) nasal spray!"ICER’s evaluation of long-term cost-effectiveness found that the fair value-based price benchmark for esketamine is between $17,700 and $25,200 per year, a range that would require a 25-52% discount from the announced list price of $32,400. Consistent with ICER’s value-assessment framework, esketamine is deemed to deliver a “low value for money” because the treatment’s incremental cost-effectiveness ratio, using the current list price, exceeds $175,000 per quality-adjusted life year (QALY) gained."Source: <a href="https://icer-review.org/announcements/trd_final_report/" target="_blank">https://icer-review.org/announcements/trd_final_report/</a></blockquote>